Science Behind Hunting Quotas Unavailable: Study

A large-scale survey of wild game regulations in North America finds science-based policies lacking, and poor transparency on the part of agencies may contribute.

Written byRuth Williams
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Bighorn sheep, British ColumbiaPAUL PAQUETResearchers have scoured documents pertaining to hundreds of hunting rules in 62 states and provinces across the U.S. and Canada for signs of science-based policy decisions. Their report, in Science Advances today (March 7), claims that many of these policies lack hallmarks of science, such as measurable objectives and independent review. But, critics argue it’s not the science that’s wanting, it’s the communication of the science to the public.

“I would dispute somewhat that science isn’t being widely applied,” says John McDonald, President of the Wildlife Society in Bethesda, Maryland, an international nonprofit association whose members include wildlife scientists, managers, educators, technicians, planners, and consultants. “Looking at all of the species they’ve assessed . . . the take, whether by hunters or trappers, is being monitored, and state and provincial agencies are looking at that harvest data, and they’re looking for indicators as to whether there is too much harvest going on.”

If it’s not available, then it is hard to evaluate. . . . And one of the cornerstones of science is that other scientists can examine the methods and independently verify the findings.—Aerin Jacob,
Yellowstone to Yukon Conservation Initiative

That said, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies